ELMD Electromed Inc Profit After Tax

Corporate emblem and logo of Electromed, Inc. (ELMD)

Electromed, Inc. (ELMD) develops lung therapy devices, implementing eco-friendly materials and energy-saving technologies in accordance with ESG standards. The business relies on the development of the SmartVest system, which helps people with COPD restore their breathing at home. The current figure is 0.01. The market valuation trend shown below clearly demonstrates the financial results of this growing manufacturer of specialized medical equipment.

Net Income: Electromed (ELMD) for 07/04/2022 - 10/30/2026

Financial and market metric breakdowns for smartvest.com (ELMD)

- market value and analyst target forecast:
Stock Price Electromed|ELMD - Price Target Chart
- market capitalization data:
Market Valuation ELMD|ELMD - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Electromed, Inc.|ELMD - Company Net Assets|Market Capitalization to Book Value Ratio smartvest.com|ELMD - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital Electromed, Inc.|ELMD - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Electromed|ELMD - Company Aggregate Debts|Debt to Book Value ELMD|ELMD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Electromed, Inc.|Quick Liquidity Indicator smartvest.com
- company profitability and valuation multiples indicators:
ELMD - Net Profit
Fundamental valuation:ELMD, Electromed Inc
Flagship merchandise of Electromed Inc

Investment capital seeks to distinguish sustainable business models from short-term speculation. Sales of SmartVest systems and ancillary consumables provide Electromed, Inc. (ELMD) with a stable operating margin. The company's financial track record reflects the daily volume of free cash flow generated for shareholders. This indicator measures the business's actual ability to create value regardless of price volatility. The positive trend of the curve confirms the high reliability of the cash flow.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|SNWV (sanuwave.com) - Final Profit|Company Net Income Outset Medical OM|LNSR - Net Income|AVITA Medical, Inc - Net Profit|Company Net Income Profound Medical Corp.|BDMD: Net Profit|Company Profit EDAP|APYX (Apyx Medical Corp) - Net Profit|IceCure Medical, Ltd. (ICCM) - Net Financial Result|Net Profit LUNG|Net Income telabio.com TELA|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS: Net Profit|Company Net Income silkroadmed.com (SILK)